Calvin Lai
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Epidemiology top 5%
- HIV, Drug Use, Sexual Risk
- Hepatitis B Virus Studies
- Substance Abuse Treatment and Outcomes
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 23
- HIV, Drug Use, Sexual Risk 22
- Substance Abuse Treatment and Outcomes 2
-
- HIV/AIDS Research and Interventions 7
- Co-authors
- Mark Tyndall (14 shared papers)Evan Wood (22 shared papers)Thomas Kerr (22 shared papers)Julio Montaner (14 shared papers)Jesse D. Raffa (3 shared papers)Jason Grebely (3 shared papers)Mel Krajden (3 shared papers)Brian Conway (2 shared papers)
- Journals
- International Journal of Drug Policy (4 papers)PLoS ONE (2 papers)The American Journal of Drug and Alcohol Abuse (2 papers)Harm Reduction Journal (2 papers)Journal of Adolescent Health (2 papers)
- Partner nations
- CanadaUnited StatesThailand
In The Last Decade
Calvin Lai
29 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Hepatology 266
- Epidemiology 685
- Toxicology 34
- Infectious Diseases 153
- Virology 34
Countries citing papers authored by Calvin Lai
This map shows the geographic impact of Calvin Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin Lai more than expected).
Fields of papers citing papers by Calvin Lai
This network shows the impact of papers produced by Calvin Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin Lai. The network helps show where Calvin Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Calvin Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 115 | |
| 2 | 2007 | 89 | |
| 3 | 2012 | 86 | |
| 4 | 2006 | 84 | |
| 5 | 2013 | 81 | |
| 6 | 2006 | 75 | |
| 7 | 2006 | 67 | |
| 8 | 2008 | 62 | |
| 9 | 2009 | 56 | |
| 10 | 2011 | 53 | |
| 11 | 2007 | 50 | |
| 12 | 2009 | 38 | |
| 13 | 2010 | 38 | |
| 14 | 2008 | 36 | |
| 15 | 2008 | 32 | |
| 16 | 2007 | 30 | |
| 17 | 2010 | 29 | |
| 18 | 2011 | 29 | |
| 19 | 2010 | 28 | |
| 20 | 2006 | 28 |
About Calvin Lai
Calvin Lai is a scholar working on Epidemiology, Infectious Diseases, General Health Professions, Public Health, Environmental and Occupational Health and Hepatology, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (22 papers), HIV/AIDS Research and Interventions (7 papers), Opioid Use Disorder Treatment (4 papers), Homelessness and Social Issues (4 papers), Hepatitis C virus research (4 papers), HIV Research and Treatment (3 papers), Forensic Toxicology and Drug Analysis (2 papers) and Substance Abuse Treatment and Outcomes (2 papers). The work is most often cited by research in Hepatology (266 citations), Epidemiology (685 citations), Toxicology (34 citations), Infectious Diseases (153 citations) and Virology (34 citations). Calvin Lai has collaborated with scholars based in Canada, United States and Thailand. Frequent co-authors include Mark Tyndall, Evan Wood, Thomas Kerr, Julio Montaner, Jesse D. Raffa, Jason Grebely, Mel Krajden, Brian Conway, Brandon D. L. Marshall and M‐J Milloy. Their work appears in journals such as International Journal of Drug Policy, PLoS ONE, The American Journal of Drug and Alcohol Abuse, Harm Reduction Journal and Journal of Adolescent Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.